Extract
ACE-011 Preclinical Data Published in the Proceedings of the National Academy of Sciences.
Results demonstrate ACE-011 increases bone formation, bone mass and bone strength
CAMBRIDGE, Mass. -- Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and musc...See the full content of this document
Sponsored links
